KN

Karan Narula

Active Director Additional Director DIN 08459053
DIN 08459053 First appointment Sep 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Karan Narula

Data last updated:

Karan Narula is an Additional Director at Hahnemann Pharmaceuticals Private Limited (since 2019). The company operates in Healthcare. Hahnemann Pharmaceuticals Private Limited reported revenue of ₹70.5 Lakh (FY 2024).

DIN 08459053
Primary Designation Additional Director
Industry Healthcare
First Appointment 02 Sep 2019
Oldest Company Age 30 yrs
Largest company Hahnemann Pharmaceuticals Private Limited · ₹70.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director02 Sep 20191996₹70.5 Lakh (FY 2024)Active

Board colleagues of Karan Narula

Directorship timeline

Open interactive timeline →
Hahnemann Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Karan Narula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karan Narula

Karan Narula currently holds 1 directorship: Hahnemann Pharmaceuticals Private Limited (Additional Director, since 02 Sep 2019, revenue ₹70.5 Lakh (FY 2024)).

Karan Narula was first appointed on 02 Sep 2019 as Additional Director at Hahnemann Pharmaceuticals Private Limited.

The current boards of Karan Narula's companies include Neeru Narula (Hahnemann Pharmaceuticals Private Limited), Pooja Narula (Hahnemann Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available